PortfoliosLab logo
Eargo, Inc. (EAR)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US2700871096

CUSIP

270087109

IPO Date

Oct 16, 2020

Highlights

Market Cap

$53.36M

EPS (TTM)

$15.00

PE Ratio

0.17

Target Price

$2.00

Short %

0.86%

Short Ratio

1.94

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Eargo, Inc.

Performance

Performance Chart


Loading data...

S&P 500

Returns By Period


EAR

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-0.63%

1M

13.31%

6M

-1.23%

1Y

9.83%

3Y*

14.42%

5Y*

14.61%

10Y*

10.64%

*Annualized

Monthly Returns

The table below presents the monthly returns of EAR, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20241.16%-1.91%-0.77%
2023-4.78%-44.75%-22.64%3.63%-1.86%3.57%-18.86%-30.75%-21.62%19.76%0.00%-0.38%-77.48%
2022-5.69%-0.00%9.98%-28.54%-58.99%-51.49%-5.57%156.34%-42.31%-37.29%-3.54%-9.48%-88.73%
202117.31%11.09%-14.48%14.59%-40.57%17.31%-9.80%-44.42%-66.37%30.76%-41.14%-1.54%-88.62%
20202.88%44.62%-10.56%33.08%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Eargo, Inc. (EAR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


There isn't enough data available to calculate the Sharpe ratio for Eargo, Inc.. This metric is based on the past 12 months of trading data. Please check back later for updated information.


Loading data...

Dividends

Dividend History


Eargo, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Eargo, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Eargo, Inc. was 99.89%, occurring on Oct 26, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.89%Feb 11, 2021682Oct 26, 2023
-26.65%Dec 23, 20207Jan 4, 20217Jan 13, 202114
-16.69%Dec 14, 20201Dec 14, 20206Dec 22, 20207
-16.54%Jan 25, 20215Jan 29, 20213Feb 3, 20218
-12.33%Oct 26, 202017Nov 17, 20205Nov 24, 202022

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Eargo, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Eargo, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 13.9% positive surprise.


-40.00-30.00-20.00-10.000.00October2020AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJuly
-0.83
-0.97
Actual
Estimate

Valuation

The Valuation section provides an overview of how Eargo, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for EAR, comparing it with other companies in the Medical Devices industry. Currently, EAR has a P/E ratio of 0.2. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for EAR relative to other companies in the Medical Devices industry. Currently, EAR has a P/S ratio of 1.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for EAR in comparison with other companies in the Medical Devices industry. Currently, EAR has a P/B value of 1.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items